Third Rock Ventures-posted 7 months ago
$32 - $35/Yr
Intern
Redwood City, CA
Securities, Commodity Contracts, and Other Financial Investments and Related Activities
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding scientists in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
